Numerate, Inc.
San Bruno, US
Biotech
Founders & leadership
BB
Bruce BoothNamed on SEC filing
GL
Guido LanzaNamed on SEC filing
SH
Steve HallNamed on SEC filing
LL
Lucio LanzaNamed on SEC filing
JG
John GriffinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2014
▶$8.2MraisedJun 2014 · 5 investors · BiotechnologyRule 506(b)
▶$8.2MraisedJun 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce BoothDirector
- Guido LanzaExecutive Officer, Director
- Steve HallDirector
- Lucio LanzaDirector
- John GriffinExecutive Officer
- Offering amount
- $9.2M
- Amount sold
- $8.2M
- First sale
- May 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $965K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2009 | $203.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Numerate, Inc. raised?
- Numerate, Inc. has disclosed $8.2M raised across 1 round.
- Where is Numerate, Inc. headquartered?
- Numerate, Inc. is headquartered in San Bruno, US.